Description
In this 6-page market guide, pricing for approved cell therapies worldwide is revealed, including:
- Apligraf
- Carticel
- Cartistem
- Cupistem
- ChondroCelect
- Dermagraft
- Epicel
- Hearticellgram
- HeartSheet
- Holoclar
- Kymriah
- Osteocel
- Prochymal
- Provenge
- Spherox
- Strimvelis
- Temcell
- Yescarta
- And more
Geographical Data on Cell Therapy Pricing
Currently, “hotspots” for cell therapy approvals include Japan, South Korea, USA, and EU.
Therefore, this report includes data from the:
- Japanese Pharmaceuticals and Medical Devices Agency (PMDA)
- South Korean Ministry of Food and Drug Safety (MFDS)
- U.S. Food and Drug Administration (FDA)
- EU European Medicines Agency (EMA)
- Other regulatory agencies worldwide
Additional analysis includes:
- Market pricing for all approved cell therapy products worldwide
- Factors influencing the market pricing of cell therapy products
- Categories of cell therapy products
This information took us dozens of hours to collect, required translators to translate pricing sheets released in various languages, and entailed calls to regulatory agencies worldwide. Now, you can have immediate access to it for only $39.
Of course, your investment is backed by a 60 Day Money Back Guarantee.
